首页 | 本学科首页   官方微博 | 高级检索  
检索        

2005~2009年我院调节血脂药使用情况分析
引用本文:韩健,刘英.2005~2009年我院调节血脂药使用情况分析[J].中国医院用药评价与分析,2010(7):602-604.
作者姓名:韩健  刘英
作者单位:首都医科大学附属北京天坛医院药剂科,北京市100050
摘    要:目的:研究我院2005~2009年调节血脂药使用情况。方法:采用药历统计软件,对2005~2009年调节血脂药的数量、金额进行统计,并计算DDDs和DDC。结果:我院调节血脂药用量逐年增大,辛伐他汀和阿托伐他汀用药量最大。结论:我院接诊的高脂蛋白血症患者数量也逐年提高,以高胆固醇血症和混合型高脂蛋白血症为主,用药较为合理。

关 键 词:调节血脂药  辛伐他汀  阿托伐他汀  DDDs

Utilization of Lipid-regulating Drugs in Our Hospital from 2005 to 2009
HAN Jian,LIU Ying.Utilization of Lipid-regulating Drugs in Our Hospital from 2005 to 2009[J].Evaluation and Analysis of Drug-Use in Hospital of China,2010(7):602-604.
Authors:HAN Jian  LIU Ying
Institution:#(Dept. of Pharmacy,Beijing Tiantan Hospital Affiliated to Capital University, Beijing 100050,China)
Abstract:OBJECTIVE: To investigate the utilization of lipid - regulating drugs in our hospital from 2005 to 2009. METHODS: The consumption amount and consumption sum of lipid - regulating drugs in our hospital from 2005 to 2009 were analyzed statistically using medication history software,meanwhile,the DDDs and DDC were calculated. RESULTS: The consumption amount of lipid - regulating drugs in our hospital increased year by year. Simvastatin and Atorvastatin took the lead in terms of consumption amount. CONCLUSION: The number of patients with hyperlipidemia (predominantly with hypercholesterolemia and mixed type of hyperlipidemia) increased year by year. The drug use for hyperlipidemia was rational on the whole.
Keywords:Lipid - regulating drug  Simvastatin  Atorvastatin  DDDs
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号